Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


02.07.2018

1 Afr J Prim Health Care Fam Med
1 AIDS Rev
1 Appl Microbiol Biotechnol
1 Arch Gynecol Obstet
2 Asian Pac J Cancer Prev
2 Biochem Biophys Res Commun
1 BMC Cancer
1 Brachytherapy
1 Cell Physiol Biochem
1 Chin Med J (Engl)
1 Clin Cancer Res
1 Eur J Obstet Gynecol Reprod Biol
1 Eur Radiol
1 Eur Rev Med Pharmacol Sci
2 Glob Health Sci Pract
8 Gynecol Oncol
1 Hum Cell
1 Int J Gynecol Cancer
1 Integr Cancer Sci Ther
1 J Cancer Educ
1 J Prev Med Hyg
1 J Virol
1 Jpn J Clin Oncol
1 Lasers Med Sci
1 Life Sci
1 Magn Reson Imaging
1 Oncologist
1 Pathol Res Pract
1 PLoS One
2 Prev Med
1 Rev Med Suisse
1 Sci Rep
1 Surg Oncol
1 Technol Cancer Res Treat
1 Urologe A
1 Zhonghua Zhong Liu Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Afr J Prim Health Care Fam Med

  1. MOFOLO N, Sello M, Leselo M, Chabanku N, et al
    Knowledge of cervical cancer, human papillomavirus and prevention among first-year female students in residences at the University of the Free State.
    Afr J Prim Health Care Fam Med. 2018;10:e1-e5.
    PubMed     Text format     Abstract available


    AIDS Rev

  2. MYERS KO, Ahmed NU
    The Role of HIV in the Progression through the Stages of the Human Papillomavirus to Cervical Cancer Pathway.
    AIDS Rev. 2018;20:94-1043.
    PubMed     Text format     Abstract available


    Appl Microbiol Biotechnol

  3. ZHU S, Zhu J, Song Y, Chen J, et al
    Bispecific affibody molecule targeting HPV16 and HPV18E7 oncoproteins for enhanced molecular imaging of cervical cancer.
    Appl Microbiol Biotechnol. 2018 Jun 25. pii: 10.1007/s00253-018-9167.
    PubMed     Text format     Abstract available


    Arch Gynecol Obstet

  4. WANG W, Liu X, Meng Q, Zhang F, et al
    Nomogram for predicting para-aortic lymph node metastases in patients with cervical cancer.
    Arch Gynecol Obstet. 2018 Jun 26. pii: 10.1007/s00404-018-4829.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  5. ALSBEIH G
    Exploring the Causes of the Low Incidence of Cervical Cancer in Western Asia
    Asian Pac J Cancer Prev. 2018;19:1425-1429.
    PubMed     Text format     Abstract available

  6. PHASWANA-MAFUYA N, Peltzer K
    Breast and Cervical Cancer Screening Prevalence and Associated Factors among Women in the South African General Population
    Asian Pac J Cancer Prev. 2018;19:1465-1470.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  7. XI C, Wang L, Yu J, Ye H, et al
    Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer.
    Biochem Biophys Res Commun. 2018 Jun 27. pii: S0006-291X(18)31469.
    PubMed     Text format     Abstract available

  8. ZHENG J, Dai X, Chen H, Fang C, et al
    Down-regulation of LHPP in cervical cancer influences cell proliferation, metastasis and apoptosis by modulating AKT.
    Biochem Biophys Res Commun. 2018 Jun 23. pii: S0006-291X(18)31441.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. PARDINI B, De Maria D, Francavilla A, Di Gaetano C, et al
    MicroRNAs as markers of progression in cervical cancer: a systematic review.
    BMC Cancer. 2018;18:696.
    PubMed     Text format     Abstract available


    Brachytherapy

  10. WALTER F, Maihofer C, Schuttrumpf L, Well J, et al
    Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
    Brachytherapy. 2018 Jun 22. pii: S1538-4721(18)30112.
    PubMed     Text format     Abstract available


    Cell Physiol Biochem

  11. WANG W, Liu X, Guo X, Quan H, et al
    Mitofusin-2 Triggers Cervical Carcinoma Cell Hela Apoptosis via Mitochondrial Pathway in Mouse Model.
    Cell Physiol Biochem. 2018;46:69-81.
    PubMed     Text format     Abstract available


    Chin Med J (Engl)

  12. LI L, Ma SQ, Tan XJ, Zhong S, et al
    Pelvic Exenteration for Recurrent and Persistent Cervical Cancer.
    Chin Med J (Engl). 2018;131:1541-1548.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  13. LEE J, Chang CL, Lin JB, Wu MH, et al
    Skeletal Muscle Loss is an Imaging Biomarker of Outcome After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.
    Clin Cancer Res. 2018 Jun 29. pii: 1078-0432.CCR-18-0788.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  14. SHIMAMOTO K, Saito T, Kitade S, Tomita Y, et al
    A study of treatments and outcomes in elderly women with cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2018;228:174-179.
    PubMed     Text format     Abstract available


    Eur Radiol

  15. THOMEER MG, Vandecaveye V, Braun L, Mayer F, et al
    Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: a multicentre study.
    Eur Radiol. 2018 Jun 25. pii: 10.1007/s00330-018-5510.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  16. ZHANG Y, Wang ZC, Zhang ZS, Chen F, et al
    MicroRNA-155 regulates cervical cancer via inducing Th17/Treg imbalance.
    Eur Rev Med Pharmacol Sci. 2018;22:3719-3726.
    PubMed     Text format     Abstract available


    Glob Health Sci Pract

  17. SILKENSEN SL, Schiffman M, Sahasrabuddhe V, Flanigan JS, et al
    Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening?
    Glob Health Sci Pract. 2018;6:242-246.
    PubMed     Text format    

  18. OUEDRAOGO Y, Furlane G, Fruhauf T, Badolo O, et al
    Expanding the Single-Visit Approach for Cervical Cancer Prevention: Successes and Lessons From Burkina Faso.
    Glob Health Sci Pract. 2018;6:288-297.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  19. ROGERI CD, Silveira HCS, Causin RL, Villa LL, et al
    Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
    Gynecol Oncol. 2018 Jun 27. pii: S0090-8258(18)30990.
    PubMed     Text format     Abstract available

  20. LEATH CA 3RD, Monk BJ
    Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years.
    Gynecol Oncol. 2018 Jun 26. pii: S0090-8258(18)31005.
    PubMed     Text format     Abstract available

  21. GOROSTIDI M, Villalain C, Ruiz R, Jaunarena I, et al
    Technique for precaval and laterocaval nodes excision at extraperitoneal paraaortic lymphadenectomy.
    Gynecol Oncol. 2018;148:233-234.
    PubMed     Text format     Abstract available

  22. ISHIKAWA M, Kasamatsu T, Tsuda H, Fukunaga M, et al
    Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.
    Gynecol Oncol. 2017 Nov 4. pii: S0090-8258(17)31449.
    PubMed     Text format     Abstract available

  23. RAUH LA, Saks EJ, Nakad-Rodriguez D, Showalter TN, et al
    Cervical cancer care in rural Virginia: The impact of distance from an academic medical center on outcomes & the role of non-specialized radiation centers.
    Gynecol Oncol. 2018 Jun 20. pii: S0090-8258(18)31001.
    PubMed     Text format     Abstract available

  24. DILLEY S, Miller K, Huh W
    HPV vaccination.
    Gynecol Oncol. 2017 Dec 12. pii: S0090-8258(17)31547.
    PubMed     Text format    

  25. DONG L, Wang MZ, Zhao XL, Feng RM, et al
    Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
    Gynecol Oncol. 2018;148:103-110.
    PubMed     Text format     Abstract available

  26. LIE AK, Trope A, Skare GB, Bjorge T, et al
    HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia.
    Gynecol Oncol. 2017 Nov 11. pii: S0090-8258(17)31453.
    PubMed     Text format     Abstract available


    Hum Cell

  27. NUNOBIKI O, Sano D, Hata S, Ogasawara T, et al
    Clinical significance of hWAPL polymorphisms in the risk of cervical carcinogenesis.
    Hum Cell. 2018;31:149-153.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  28. DOSTALEK L, Avall-Lundqvist E, Creutzberg CL, Kurdiani D, et al
    ESGO Survey on Current Practice in the Management of Cervical Cancer.
    Int J Gynecol Cancer. 2018 Jun 28. doi: 10.1097/IGC.0000000000001314.
    PubMed     Text format     Abstract available


    Integr Cancer Sci Ther

  29. SAGLAM O, Conejo-Garcia J
    PD-1/PD-L1 immune checkpoint inhibitors in advanced cervical cancer.
    Integr Cancer Sci Ther. 2018;5.
    PubMed     Text format     Abstract available


    J Cancer Educ

  30. LYSON HC, Le GM, Zhang J, Rivadeneira N, et al
    Social Media as a Tool to Promote Health Awareness: Results from an Online Cervical Cancer Prevention Study.
    J Cancer Educ. 2018 Jun 11. pii: 10.1007/s13187-018-1379.
    PubMed     Text format     Abstract available


    J Prev Med Hyg

  31. GAMAOUN R
    Awareness and knowledge about cervical cancer prevention methods among Tunisian women.
    J Prev Med Hyg. 2018;59:E30-E35.
    PubMed     Text format     Abstract available


    J Virol

  32. WOAPPI Y, Hosseinipour M, Creek KE, Pirisi L, et al
    Stem Cell Properties of Normal Human Keratinocytes Determine Transformation Responses to Human Papillomavirus 16 DNA.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    Jpn J Clin Oncol

  33. NISHIO H, Iwata T, Nomura H, Morisada T, et al
    Liquid-based cytology versus conventional cytology for detection of uterine cervical lesions: a prospective observational study.
    Jpn J Clin Oncol. 2018;48:522-528.
    PubMed     Text format     Abstract available


    Lasers Med Sci

  34. WANG J, Li L, Yang P, Chen Y, et al
    Identification of cervical cancer using laser-induced breakdown spectroscopy coupled with principal component analysis and support vector machine.
    Lasers Med Sci. 2018 Jun 26. pii: 10.1007/s10103-018-2500.
    PubMed     Text format     Abstract available


    Life Sci

  35. ZHANG LZ, Huang LY, Huang AL, Liu JX, et al
    CRIP1 promotes cell migration, invasion and epithelial-mesenchymal transition of cervical cancer by activating the Wnt/betacatenin signaling pathway.
    Life Sci. 2018 Jun 26. pii: S0024-3205(18)30322.
    PubMed     Text format     Abstract available


    Magn Reson Imaging

  36. THAPA D, Wang P, Wu G, Wang X, et al
    A histogram analysis of diffusion and perfusion features of cervical cancer based on intravoxel incoherent motion magnetic resonance imaging.
    Magn Reson Imaging. 2018 Jun 25. pii: S0730-725X(18)30181.
    PubMed     Text format     Abstract available


    Oncologist

  37. BATEMAN LB, Blakemore S, Koneru A, Mtesigwa T, et al
    Barriers and Facilitators to Cervical Cancer Screening, Diagnosis, Follow-Up Care and Treatment: Perspectives of Human Immunodeficiency Virus-Positive Women and Health Care Practitioners in Tanzania.
    Oncologist. 2018 Jun 22. pii: theoncologist.2017-0444.
    PubMed     Text format     Abstract available


    Pathol Res Pract

  38. SHI X, Li B, Yuan Y, Chen L, et al
    The possible association between the presence of an MPO -463 G>A (rs2333227) polymorphism and cervical cancer risk.
    Pathol Res Pract. 2018 May 22. pii: S0344-0338(18)30249.
    PubMed     Text format     Abstract available


    PLoS One

  39. KELLY PJ, Allison M, Ramaswamy M
    Cervical cancer screening among incarcerated women.
    PLoS One. 2018;13:e0199220.
    PubMed     Text format     Abstract available


    Prev Med

  40. LOFTERS AK, Vahabi M, Pyshnov T, Kupets R, et al
    Segmenting women eligible for cervical cancer screening using demographic, behavioural and attitudinal characteristics.
    Prev Med. 2018 Jun 22. pii: S0091-7435(18)30202.
    PubMed     Text format     Abstract available

  41. MAZA M, Melendez M, Masch R, Alfaro K, et al
    Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador.
    Prev Med. 2018 Jun 26. pii: S0091-7435(18)30206.
    PubMed     Text format     Abstract available


    Rev Med Suisse

  42. DUVOISIN CORDOBA C, Clerc D, Vanoni A, Pache B, et al
    [Screening for anal cancer : is it the same as for cervical cancer ?]
    Rev Med Suisse. 2018;14:1230-1236.
    PubMed     Text format     Abstract available


    Sci Rep

  43. MARRERO-RODRIGUEZ D, Taniguchi-Ponciano K, Subramaniam M, Hawse JR, et al
    Kruppel-Like Factor 10 participates in cervical cancer immunoediting through transcriptional regulation of Pregnancy-Specific Beta-1 Glycoproteins.
    Sci Rep. 2018;8:9445.
    PubMed     Text format     Abstract available


    Surg Oncol

  44. ZOU R, Chen X, Jin X, Li S, et al
    Up-regulated BCAR4 contributes to proliferation and migration of cervical cancer cells.
    Surg Oncol. 2018;27:306-313.
    PubMed     Text format     Abstract available


    Technol Cancer Res Treat

  45. LI X, Yin G, Li J, Wu A, et al
    The Correlation Between TNF-alpha Promoter Gene Polymorphism and Genetic Susceptibility to Cervical Cancer.
    Technol Cancer Res Treat. 2018;17:1533033818782793.
    PubMed     Text format     Abstract available


    Urologe A

  46. HUCK N
    [Prophylactic vaccination against HP viruses for the prevention of cervical cancer : Implementation of gender neutral, prophylactic vaccination in Germany as an effective instrument for prevention].
    Urologe A. 2018 Jun 26. pii: 10.1007/s00120-018-0712.
    PubMed     Text format    


    Zhonghua Zhong Liu Za Zhi

  47. TANG Q, Tu YQ, Chen JH, Lyu XJ, et al
    [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
    Zhonghua Zhong Liu Za Zhi. 2018;40:462-466.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: